BCM
QGENF

Bayesian Capital Management’s QIAGEN NV QGENF Stock Holding History

Bayesian Capital Management’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-31,500
Closed -$883K – 839
2016
Q4 		$883K Buy
31,500
+13,357
+74% +$374K 0.22% 161
2016
Q3 		$498K Buy
+18,143
New +$498K 0.33% 110

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Bayesian Capital Management's QGENF Position: Q1 2017 in Review

Bayesian Capital Management sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 31,500 shares — an estimated $883K sold.

Bayesian Capital Management first reported a position in QGENF in Q3 2016 and held it in 2 quarters. The position peaked at $883K in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Bayesian Capital Management reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Bayesian Capital Management sold 31,500 QIAGEN NV shares in Q1 2017, an estimated $883K.
  • Bayesian Capital Management first reported a position in QIAGEN NV in Q3 2016 and held it in 2 quarters.
  • Bayesian Capital Management's QIAGEN NV position peaked at $883K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Bayesian Capital Management's 13F filing for Q1 2017, filed 15 May 2017.